6-K ·Filed Jun 1, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001654954-26-005587
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine employee share issuance with immaterial dilution. No trading action warranted. Monitor for any future material filings such as earnings or pipeline updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
AZN ▼ -5.55% at T+60d
NEUTRAL call ✗ call lost -5.55% · α vs SPY -6.52% · entry $179.55 → $169.59
Entry anchored
Jun 1, 2026
via day open
T+1d
-1.20%
call -1.20% · α -1.35%
$177.39
settled 4mo ago
T+5d
+3.57%
call +3.57% · α +6.32%
$185.95
settled 4mo ago
T+20d
+6.35%
call +6.35% · α +8.66%
$190.95
settled 3mo ago
T+60d
-5.55%
call -5.55% · α -6.52%
$169.59
settled 5w ago

Price Chart

Loading chart...

Executive Summary

AstraZeneca filed a 6-K reporting the admission of 14,120 ordinary shares to trading on the London Stock Exchange, issued under an existing employee share scheme block admission from January 2021. This is a routine administrative filing with no material financial or strategic impact.

Key Facts

  • 14,120 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange Main Market.
  • Total shares in issue post-admission: 1,551,009,750.
  • Shares were issued under an existing block admission dated 29 January 2021 for employee share schemes.
  • The admission covers shares issued between 1 May 2026 and 31 May 2026.
  • No prospectus or supplementary prospectus was filed.

Financial Impact

Dilution from 14,120 new shares is negligible — approximately 0.0009% of total shares outstanding.

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-005587
Document: 0001654954-26-005587-index-headers.html0001654954-26-005587
Document: 0001654954-26-005587-index.html0001654954-26-005587
Document: 0001654954-26-005587.txt0001654954-26-005587
54 reports for AZN
Performance horizon
67% Hit rate 20 of 30 directional calls best @ T+60▲ +13.65%Jul 6, 2026
Filters
Rows
Reports for AZN — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$161.85 $168.37▲ +4.03%▲ +1.90%$156.93 (−3.04%)
Sep 14, 2026
18d ago
6-K
BEARISH ★ 5/10
$163.78 $168.10▼ −2.64%▼ −2.53%$156.93 (+4.18%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 7/10
$160.04 $161.85▲ +1.13%▲ +2.25%$156.93 (−1.94%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.93 (−3.26%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.93 (−3.26%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$162.47 $156.94▼ −3.40%▼ −3.49%$156.93 (−3.41%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.93 (−3.26%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$162.22 $156.94▼ −3.25%▼ −3.33%$156.93 (−3.26%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 7/10
$162.47 $156.94▼ −3.40%▼ −3.49%$156.93 (−3.41%)
Aug 31, 2026
4w ago
Court Ruling
BEARISH ★ 3/10
$162.13 $159.95▲ +1.34%▲ +1.20%$156.93 (+3.20%)
Showing 10 of 54

US Market Status

Market Open — Closes in 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access